Communiqués Insulet Corporation

Actions

PODD

US45784P1012

Equipement, fournitures et distribution médicale

Temps réel estimé Cboe BZX Autres places de cotation 19:22:22 20/06/2025			Varia. 5j.	Varia. 1 janv.
301,46 ^USD	-0,11%		-1,06%	+15,45%

16/06	INSULET CORPORATION : Truist Securities revoit son opinion à la hausse	ZM
10/06	L'application Omnipod 5 d'Insulet Corporation pour iPhone avec intégration Dexcom G7 est désormais disponible pour tous les utilisateurs américains.	CI

Communiqués

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod(R) 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions	16:21	AQ
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions	19/06	BU
Latest Developments On Confidentiality At The UPC	16/06	AQ
Insulet's Omnipod 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users	11/06	AQ
Insulet : and Marvel Collaborate to Launch Comic Book Hero with Type 1 Diabetes Featuring Omnipod® 5, Empowering the Diabetes Community Through Representation	11/06	PU
Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users	10/06	BU
Insulet Corp.'s Trade Secrets Jury Award Reduced From $452 Million To $59.4 Million To Avoid Double Recovery	05/06	AQ
Insulet : 2024 Conflict Minerals Report	29/05	PU
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025	23/05	BU
Intellectual Property Law Insights, May 12, 2025	14/05	AQ
Insulet Announces Publication of 2024 Sustainability Report	13/05	BU
Insulet : 2024 ESG Data	12/05	PU
Insulet : Corporate Presentation - May 2025	08/05	PU
Insulet : Q1 2025 Insulet Corporation Earnings Call	08/05	PU
Insulet: Q1 Earnings Snapshot	08/05	AQ
Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)	08/05	BU
Court Orders Patent Reassignment As Trade Secret Misappropriation Remedy In Insulet Case	06/05	AQ
Insulet Appoints Ashley McEvoy President and CEO	28/04	BU
Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above	07/04	AQ
Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025	03/04	BU
Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections	20/03	AQ
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections	19/03	BU
Insulet Corp. May Have To Choose Between $452 Million Jury Award Or Permanently Blocking Competitor From Utilizing Its Trade Secrets	19/03	AQ
Insulet Announces Pricing of Senior Notes Due 2033	18/03	BU
Insulet Announces Proposed Financing Transactions	18/03	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Insulet Corporation

Actions

PODD

US45784P1012

Equipement, fournitures et distribution médicale

Communiqués

Filtres